Life Insurance Corporation of India (LIC) announced on Wednesday that it has increased its ownership of Divis Laboratories to 5% through the purchase of additional shares for Rs 35.82 crore.
As its holdings in Divis Laboratories climbed from 1,32,54,663 to 1,33,60,663, LIC reported that its ownership in the company increased from 4.992% to 5.032%.
The company’s holdings surpassed the 5% threshold on November 7, 2022. According to LIC’s regulatory filing, the average price paid for the shares was Rs3,379.01
Listed firms are required by regulatory disclosure standards to notify the stock exchanges of changes in shareholding of 5% or more.
Divis Laboratories manufactures nutraceutical components, intermediates, and active pharmaceutical ingredients (APIs) with a focus on exports.
On the BSE, shares of LIC closed at Rs631.20 each, down 0.33%, while shares of Divis Lab closed at Rs3,298.15, down 3.38%.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
